{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T22:21:42Z","timestamp":1791584502798,"version":"4.3.4"},"reference-count":45,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.bbrc.2020.03.051","type":"journal-article","created":{"date-parts":[[2020,3,21]],"date-time":"2020-03-21T01:51:26Z","timestamp":1584755486000},"page":"231-238","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"title":["Ibudilast enhances the clearance of SOD1 and TDP-43 aggregates through TFEB-mediated autophagy and lysosomal biogenesis: The new molecular mechanism of ibudilast and its implication for neuroprotective therapy"],"prefix":"10.1016","volume":"526","author":[{"given":"Yanming","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongfeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1099-0509","authenticated-orcid":false,"given":"Zheng","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingzhi","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2020.03.051_bib1","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nrd3050","article-title":"Protein aggregation diseases: pathogenicity and therapeutic perspectives","volume":"9","author":"Aguzzi","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbrc.2020.03.051_bib2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.neurol.2008.02.043","article-title":"Parkinson disease and amyotrophic lateral sclerosis tauopathies, TDP-43 and SOD mutations","volume":"165","author":"Le Forestier","year":"2008","journal-title":"Rev. Neurol."},{"key":"10.1016\/j.bbrc.2020.03.051_bib3","doi-asserted-by":"crossref","first-page":"11648","DOI":"10.1074\/jbc.M414327200","article-title":"Oxidative modifications and aggregation of Cu, Zn-superoxide dismutase associated with Alzheimer and Parkinson diseases","volume":"280","author":"Choi","year":"2005","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2020.03.051_bib4","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1365-2567.2009.03225.x","article-title":"Inflammation in neurodegenerative diseases","volume":"129","author":"Amor","year":"2010","journal-title":"Immunology"},{"key":"10.1016\/j.bbrc.2020.03.051_bib5","first-page":"337","article-title":"The Nobel Lectures in Immunology. The Nobel prize for physiology or medicine, 1960. Immunological tolerance","volume":"33","author":"Medawar","year":"1991","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.bbrc.2020.03.051_bib6","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.tips.2004.11.007","article-title":"Multi-functional drugs for various CNS targets in the treatment of neurodegenerative disorders","volume":"26","author":"Youdim","year":"2005","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bbrc.2020.03.051_bib7","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3109\/02770909209048938","article-title":"Effect of ibudilast: a novel anti-asthmatic agent, on airway hyper-sensitivity in bronchial asthma","volume":"29","author":"Kawasaki","year":"1992","journal-title":"J.\u00a0Asthma"},{"key":"10.1016\/j.bbrc.2020.03.051_bib8","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.neuropharm.2003.09.009","article-title":"Neuroprotective role of phosphodiesterase inhibitor ibudilast on neuronal cell death induced by activated microglia","volume":"46","author":"Mizuno","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbrc.2020.03.051_bib9","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0006-8993(99)01666-2","article-title":"Ibudilast suppresses TNF\u03b1 production by glial cells functioning mainly as type III phosphodiesterase inhibitor in the CNS","volume":"837","author":"Suzumura","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.bbrc.2020.03.051_bib10","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41582-018-0082-z","article-title":"Treatment of multiple sclerosis-success from bench to bedside","volume":"15","author":"Tintore","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.bbrc.2020.03.051_bib11","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.cct.2016.08.009","article-title":"Design, rationale, and baseline characteristics of the randomized double-blind phase II clinical trial of ibudilast in progressive multiple sclerosis","volume":"50","author":"Fox","year":"2016","journal-title":"Contemp. Clin. Trials"},{"key":"10.1016\/j.bbrc.2020.03.051_bib12","volume":"88","author":"Brooks","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.bbrc.2020.03.051_bib13","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1056\/NEJMoa1803583","article-title":"For the NN102\/SPRINT-MS trial investig, phase 2 trial of ibudilast in progressive multiple sclerosis N","volume":"379","author":"Fox","year":"2018","journal-title":"Engl. J. Med."},{"key":"10.1016\/j.bbrc.2020.03.051_bib14","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.molmed.2011.06.004","article-title":"TDP-43 functions and pathogenic mechanisms implicated in TDP-43 proteinopathies","volume":"17","author":"Cohen","year":"2011","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.bbrc.2020.03.051_bib15","first-page":"1205","article-title":"Amyotrophic lateral sclerosis, frontotemporal dementia and beyond: the TDP-43 diseases","volume":"256","author":"Geser","year":"2009","journal-title":"J.\u00a0Neurol."},{"key":"10.1016\/j.bbrc.2020.03.051_bib16","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.neuron.2004.06.016","article-title":"Toxicity of familial ALS-linked SOD1 mutants from selective recruitment to spinal mitochondria","volume":"43","author":"Liu","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.bbrc.2020.03.051_bib17","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1126\/science.288.5465.399a","article-title":"Toxicity of ALS-linked SOD1 mutants","volume":"288","author":"Williamson","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2020.03.051_bib18","doi-asserted-by":"crossref","first-page":"3617","DOI":"10.1073\/pnas.0730423100","article-title":"Misfolded CuZnSOD and amyotrophic lateral sclerosis","volume":"100","author":"Valentine","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bbrc.2020.03.051_bib19","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.neuron.2004.06.021","article-title":"Amyotrophic lateral sclerosis-associated SOD1 mutant proteins bind and aggregate with Bcl-2 in spinal cord mitochondria","volume":"43","author":"Pasinelli","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.bbrc.2020.03.051_bib20","doi-asserted-by":"crossref","first-page":"4268","DOI":"10.1093\/hmg\/ddp380","article-title":"Gp78, an ER associated E3, promotes SOD1 and ataxin-3 degradation","volume":"18","author":"Ying","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrc.2020.03.051_bib21","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1126\/science.281.5384.1851","article-title":"Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1","volume":"281","author":"Bruijn","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2020.03.051_bib22","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.neuron.2013.07.033","article-title":"Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis","volume":"79","author":"Ling","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.bbrc.2020.03.051_bib23","doi-asserted-by":"crossref","first-page":"R46","DOI":"10.1093\/hmg\/ddq137","article-title":"TDP-43 and FUS\/TLS: emerging roles in RNA processing and neurodegeneration","volume":"19","author":"Lagier-Tourenne","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrc.2020.03.051_bib24","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.conb.2011.05.029","article-title":"Understanding the role of TDP-43 and FUS\/TLS in ALS and beyond","volume":"21","author":"Da Cruz","year":"2011","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.bbrc.2020.03.051_bib25","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.tins.2011.05.002","article-title":"TDP-43 and FUS: a nuclear affair","volume":"34","author":"Dormann","year":"2011","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.bbrc.2020.03.051_bib26","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/hmg\/ddv450","article-title":"Folliculin, a tumor suppressor associated with Birt-Hogg-Dube (BHD) syndrome, is a novel modifier of TDP-43 cytoplasmic translocation and aggregation","volume":"25","author":"Xia","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrc.2020.03.051_bib27","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.neulet.2009.11.055","article-title":"Degradation of TDP-43 and its pathogenic form by autophagy and the ubiquitin-proteasome system","volume":"469","author":"Wang","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbrc.2020.03.051_bib28","doi-asserted-by":"crossref","first-page":"6270","DOI":"10.1007\/s12035-015-9537-z","article-title":"Parkin protects against misfolded SOD1 toxicity by promoting its aggresome formation and autophagic clearance","volume":"53","author":"Yung","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bbrc.2020.03.051_bib29","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/nrm1742","article-title":"Opinion: what is the role of protein aggregation in neurodegeneration?","volume":"6","author":"Ross","year":"2005","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbrc.2020.03.051_bib30","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/nm.3232","article-title":"The role of autophagy in neurodegenerative disease","volume":"19","author":"Nixon","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2020.03.051_bib31","doi-asserted-by":"crossref","first-page":"28576","DOI":"10.1074\/jbc.M111.299990","article-title":"Ataxin-3 regulates aggresome formation of copper-zinc superoxide dismutase (SOD1) by editing K63-linked polyubiquitin chains","volume":"287","author":"Wang","year":"2012","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2020.03.051_bib32","doi-asserted-by":"crossref","first-page":"121","DOI":"10.15252\/embj.201591998","article-title":"TDP-43 loss of function increases TFEB activity and blocks autophagosome-lysosome fusion","volume":"35","author":"Xia","year":"2016","journal-title":"EMBO J."},{"key":"10.1016\/j.bbrc.2020.03.051_bib33","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1093\/hmg\/ddr021","article-title":"TAR DNA-binding protein 43 (TDP-43) regulates stress granule dynamics via differential regulation of G3BP and TIA-1","volume":"20","author":"McDonald","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrc.2020.03.051_bib34","doi-asserted-by":"crossref","first-page":"8516","DOI":"10.1074\/jbc.M809462200","article-title":"Expression of TDP-43 c-terminal fragments in\u00a0vitro recapitulates pathological features of TDP-43 proteinopathies","volume":"284","author":"Igaz","year":"2009","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2020.03.051_bib35","doi-asserted-by":"crossref","first-page":"7607","DOI":"10.1073\/pnas.0900688106","article-title":"Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity","volume":"106","author":"Zhang","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bbrc.2020.03.051_bib36","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1111\/j.1462-5822.2006.00714.x","article-title":"Autophagy and antigen presentation","volume":"8","author":"Munz","year":"2006","journal-title":"Cell Microbiol."},{"key":"10.1016\/j.bbrc.2020.03.051_bib37","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1016\/j.biocel.2004.02.005","article-title":"Methods for monitoring autophagy","volume":"36","author":"Mizushima","year":"2004","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.bbrc.2020.03.051_bib38","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4161\/auto.1.1.1513","article-title":"Autophagy and its possible roles in nervous system diseases, damage and repair","volume":"1","author":"Rubinsztein","year":"2005","journal-title":"Autophagy"},{"key":"10.1016\/j.bbrc.2020.03.051_bib39","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1080\/15548627.2015.1066957","article-title":"A1 disrupts autophagic flux by inhibiting both V-ATPase-dependent acidification and Ca-P60A\/SERCA-dependent autophagosome-lysosome fusion","volume":"11","author":"Mauvezin","year":"2015","journal-title":"Autophagy"},{"key":"10.1016\/j.bbrc.2020.03.051_bib40","doi-asserted-by":"crossref","DOI":"10.15252\/embj.201798804","article-title":"The complex relationship between TFEB transcription factor phosphorylation and subcellular localization","volume":"37","author":"Puertollano","year":"2018","journal-title":"EMBO J."},{"key":"10.1016\/j.bbrc.2020.03.051_bib41","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/ncb3407","article-title":"Protein kinase C controls lysosome biogenesis independently of mTORC1","volume":"18","author":"Li","year":"2016","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbrc.2020.03.051_bib42","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1038\/s41467-017-02332-3","article-title":"Small-molecule TFEB pathway agonists that ameliorate metabolic syndrome in mice and extend C. elegans lifespan","volume":"8","author":"Wang","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2020.03.051_bib43","doi-asserted-by":"crossref","first-page":"e2347","DOI":"10.1038\/cddis.2016.243","article-title":"Fucosylation of LAMP-1 and LAMP-2 by FUT1 correlates with lysosomal positioning and autophagic flux of breast cancer cells","volume":"7","author":"Tan","year":"2016","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbrc.2020.03.051_bib44","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.molcel.2016.09.037","article-title":"An autophagic flux probe that releases an internal control","volume":"64","author":"Kaizuka","year":"2016","journal-title":"Mol. Cell."},{"key":"10.1016\/j.bbrc.2020.03.051_bib45","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1083\/jcb.152.4.657","article-title":"Dissection of autophagosome formation using Apg5 deficient mouse embryonic stem cells","volume":"152","author":"Mizushima","year":"2001","journal-title":"J.\u00a0Cell Biol."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X20305313?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X20305313?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T11:48:48Z","timestamp":1757764128000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X20305313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S0006291X20305313"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2020.03.051","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ibudilast enhances the clearance of SOD1 and TDP-43 aggregates through TFEB-mediated autophagy and lysosomal biogenesis: The new molecular mechanism of ibudilast and its implication for neuroprotective therapy","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2020.03.051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}